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• She was diagnosed with Graves' disease 26 years ago and underwent subtotal thyroidectomy as definite treatment.
• Post-operatively, she was commenced on 100mcg of levothyroxine and continued to have regular follow up with her GP.
• It was noted that her levothyroxine dose had to be reduced to 50 mcg daily over a period of 10 years due to persistently suppressed TSH levels with free T4 levels within the normal range.
• In January 2015, her thyroid function showed a picture suggestive of over-replacement with TSH <0.01 (0.3-4.2) milliunit/L, free T3 of 6.3 (2.5-5.7) pmol/L and free T4 of 24 (9-23) pmol/L. Therefore, her levothyroxine dose was further decreased to 50 mcg on alternate days by her GP.
• In November 2016, she was seen in our endocrine clinic while on the above levothyroxine regimen.
• She didn't report any symptoms related to thyrotoxicosis or overreplacement.
Introduction:
• Treatment options for Graves' disease include antithyroid drugs, radioiodine ablation and surgery.
• Thyroid surgery for Graves' disease commonly falls into one of three categories: 1) total thyroidectomy, which aims to achieve complete macroscopic removal of thyroid tissue; 2) bilateral subtotal thyroidectomy, in which bilateral thyroid remnants are left; and 3) unilateral total and contralateral subtotal thyroidectomy, or the Dunhill procedure.
• Total thyroidectomy removes target tissue for the thyroid-stimulating hormone receptor antibody. It controls hyperthyroidism at the cost of lifelong thyroxin replacement. Subtotal thyroidectomy leaves a thyroid remnant and may be less likely to lead to complications, however a higher rate of recurrent hyperthyroidism is expected and revision surgery would be challenging • We present a case of thyroid function recovery more than two decades after subtotal thyroidectomy with active remnants and positive TSH receptor antibodies.
Investigations:
• Repeat thyroid function sowed TSH of 0.01 (0.3-4.2) milliunit/L, free T3 of 4.3 (2.5-5.7) pmol/L, free T4 of 14.5 (9-23) pmol/L and a positive TSH receptor antibody level of 2.9 (<0.4) unit/ml.
• She underwent a thyroid ultrasound that showed three hypervascular nodules (thyroid remnants) in the thyroid bed (Fig 1) .
• A Tc-99m uptake scan was suggestive of multiple toxic nodules: two large nodules in the left with high increased tracer uptake and another smaller nodule in the right mid pole of the thyroid with low level activity (Fig 2) .
Management:
• Levothyroxine was withheld In October 2017
• Serial TFT's done subsequently showed evidence of euthyroidism with her latest results in July 2018 (Fig 3) showing TSH of 0.64 (0.3-4.2) milliunit/L, free T4 of 11.7 (9-23) pmol/L and TSH receptor antibody level of 1.5 (<0.4) unit/ml. • She remains under regular surveillance as she is at high risk of Graves' disease recurrence.
Discussion:
• In the past subtotal thyroidectomy was commonly performed. Current guidelines recommend that if surgery is chosen as treatment for Graves' disease, total thyroidectomy is the preferred surgery.
• This is due to the fact that total thyroidectomy has a nearly 0% risk of recurrence, whereas subtotal thyroidectomy may have an 8% chance of persistence or recurrence of hyperthyroidism at 5 years.
• A recent Cochrane review showed that total thyroidectomy was more effective than subtotal thyroidectomy techniques (both bilateral subtotal thyroidectomy and the Dunhill procedure) at preventing recurrent hyperthyroidism (OR 0.14 (95% CI 0.04 to 0.46) with follow up period range from 6 months to 6 years.
• A recent study from a single centre followed retrospectively 385 patients who underwent bilateral subtotal thyroidectomy and 57 patients who underwent the Hartley-Dunhill operation with median postoperative follow-up time of 72 months (range 12-144 months). This study found that persistent or recurrent hyperthyroidism was observed in 119 (28.7%) patients with euthyroid state achieved in only 19.3% of patients.
• This case illustrates that clinicians should be aware of the risk of Graves' disease recurrence with previous subtotal thyroidectomy. 
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